AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease

NCT00528424 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
286
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Endo Pharmaceuticals